Page last updated: 2024-08-26

lysophosphatidic acid and African Lymphoma

lysophosphatidic acid has been researched along with African Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barz, D; Berod, L; Idzko, M; Kamradt, T; Lagadari, M; Lehmann, K; Maghazachi, AA; Norgauer, J; Truta-Feles, K; Ziemer, M1
Banerji, V; Gibson, SB; Hu, X; Johnston, JB; Mendoza, FJ; Sun, J1

Other Studies

2 other study(ies) available for lysophosphatidic acid and African Lymphoma

ArticleYear
Lysophosphatidic acid inhibits the cytotoxic activity of NK cells: involvement of Gs protein-mediated signaling.
    International immunology, 2009, Volume: 21, Issue:6

    Topics: Burkitt Lymphoma; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Down-Regulation; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Humans; Immunologic Surveillance; Killer Cells, Natural; Lysophospholipids; Melanoma; p38 Mitogen-Activated Protein Kinases; Perforin; Phosphatidylinositol 3-Kinases; Receptors, Lysophosphatidic Acid; Signal Transduction; Tumor Escape

2009
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.
    Cellular signalling, 2008, Volume: 20, Issue:6

    Topics: Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoproliferative Disorders; Lysophospholipids; Multiple Myeloma; Mutagens; NF-kappa B; RNA, Messenger; Vascular Endothelial Growth Factor A; Vidarabine

2008